IND-SWIFT LABORATORIES LTD. - 532305 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot21-05-2024
IND-SWIFT LABORATORIES LTD. - 532305 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal BallotIND-SWIFT LABORATORIES LTD. - 532305 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 18, 2024.
Outcome of Board meeting dated May 18, 2024IND-SWIFT LABORATORIES LTD. - 532305 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Please refer attahed PDF.IND-SWIFT LABORATORIES LTD. - 532305 - Compliances-Reg. 54 - Asset Cover details
Please refer attached pdf.IND-SWIFT LABORATORIES LTD. - 532305 - Financial Results For The Year Ended On 31St March, 2024
Please refer attached pdfIND-SWIFT LABORATORIES LTD. - 532305 - Board Meeting Outcome for Board Meeting Held On May 13, 2024
Outcome of Board Meeting held on May 13, 2024IND-SWIFT LABORATORIES LTD. - 532305 - Board Meeting Intimation for Notice Of Board Meeting Pursuant To Regulation 29 Of SEBI (LODR) Regulations, 2015
IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company for the Quarter and Year ended March 31, 2024.IND-SWIFT LABORATORIES LTD. - 532305 - Report Under Regulation 10(7) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Please find the attached report received by the Company from M/s. Essix Biosciences Limited.IND-SWIFT LABORATORIES LTD. - 532305 - Announcement under Regulation 30 (LODR)-Acquisition
We wish to inform you that the Company has approved the incorporation of a wholly owned subsidiary in Dubai, UAE.